ArticleBMJ open2023

Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with poor ovarian response: protocol for a multicentre, randomised, controlled trial.

Xianghui Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.